Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07211984) titled 'Evaluation of Dalia Solution For Depressed Patient' on Oct. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Dalia Care
Condition:
Depression Chronic
Depressed
Depressed Mood
Depression and Quality of Life
Depression Diagnosis
Intervention:
Device: Dalia Monitoring
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 10, 2025
Target Sample Size: 644
Countries of Recruitment:
France
To know more, visit https://clinicaltrials.gov/study/NCT072119...